The same research group that initially identified CEA subsequently indicated that CEA levels could be measured in serum from patients with colorectal and other carcinomas [3], which introduced the possibility of clinical application for diagnosis, monitoring and prognosis. Here, CEACAM5 is linked to carcinoma.